NIH awards SBIR grant to AVM for lymphoma drug research 25-Aug-2022 By Jenni Spinner The National Institutes of Health grant to AVM Biotechnology will be used to evaluate a drug to treat non-Hodgkin’s lymphoma combined with standard of care.